Craig-Hallum analyst Jeremy Hamblin upgrades Carrols Restaurant Group (NASDAQ:TAST) from Hold to Buy.
Vera Therapeutics Stock Is Trading Higher Today – Here’s Why
On Saturday, Vera Therapeutics Inc (NASDAQ: VERA) announced that the Phase 2b ORIGIN trial of atacicept for the treatment of IgA nephropathy (IgAN) met its primary and key secondary endpoints, with statistically significant and clinically meaningful reductions in proteinuria and
